The Oncology Institute, Inc.
NCM: TOILive Quote
About The Oncology Institute, Inc.
Healthcare
Medical Care Facilities
The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
📊 Fundamental Analysis
The Oncology Institute, Inc. demonstrates a profit margin of -12.1%, which is below the sector average, suggesting competitive pressure.
The company recently reported 41.6% revenue growth, which is well above average for the Healthcare sector.
At a current price of $3.08, TOI currently sits at the 42nd percentile of its 52-week range (Range: $1.80 - $4.88).
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Revenue Growth
Excellent
✅
Beta (Risk)
Low Volatility
Key Financials
Market Cap
$495.92M
Trailing P/E
--
Forward P/E
-19.25
Beta (5Y)
0.20
52W High
$4.88
52W Low
$1.80
Avg Volume
1.97M
Day High
Day Low
📡 Subscribe to ZcoreAI updates
Join the list to get access to:
- Z-Score signals at market open
- New app features and updates
- Exclusive promo for ZcoreAI App